Current and novel theranostic modalities for knee osteoarthritis

Osteoarthritis is the second most common disorder after heart disease. This progressive degenerative disease affects the knee joint more than any others. The exact etiology of knee osteoarthritis is not clear, however, there are many predisposing factors such as obesity, age, gender, etc., that can increase the incidence and prevalence of this disease. Early diagnosis in knee osteoarthritis is very important. Despite the variety of diagnostic methods, lack of a valid and reliable diagnostic approach to detect the disorder in early stages has always been a challenge for researchers. Establishing an efficient therapeutic protocol for these patients is another crucial challenge. Recently, in addition to conventional treatments, which are surgical and non-surgical, tissue engineering and regenerative medicine as novel therapeutic modalities have received remarkable attention. In this paper, current diagnostic and therapeutic methods for knee osteoarthritis are discussed and potential biomarkers for early diagnosis and monitoring the clinical condition are discussed.

1. Ho K.W., Pong G., Poon W.C., et al. Progression of health-related quality of life of patients waiting for total knee arthroplasty. J Eval Clin Pract. 2021 Feb; 27(1): 69-74. https://doi.org/10.1111/ jep.13388. PMID: 32202045

2. Xiao Z.F., Su G.Y., Hou Y., et al. Cartilage degradation in osteoarthritis: A process of osteochondral remodeling resembles the endochondral ossification in growth plate? Med Hypotheses. 2018 Dec; 121: 183-187. https://doi.org/10.1016/j.mehy.2018.08.023. PMID: 30396477

3. LiuD., Liang Y.H., Yang Y.T., et al. Circular RNA in osteoarthritis: an updated insight into the pathophysiology and therapeutics. Am J Transl Res. 2021 Jan 15; 13(1): 11-23. PMID: 33527005

4. Li Y., Liu F., Xu X., et al. A novel variant near LSP1P3 is associated with knee osteoarthritis in the Chinese population. Clin Rheumatol. 2020 Aug; 39(8): 2393-2398. https://doi.org/10.1007/s10067-020-04995-8. PMID:32103374

5. Katz J.N., Arant K.R., Loeser R.F. Diagnosis and treatment of hip and knee osteoarthritis: A review. JAMA. 2021 Feb 9; 325(6): 568578. https://doi.org/rn.m01/jama.2020.22171. PMID: 33560326

6. Yang G.Y., Guo H.L., Li T., et al. The medial compartment and patellofemoral joint degenerate more severely in early stage knee osteoarthritis: a cross-sectional study. Eur Rev Med Pharmacol Sci. 2020 Oct; 24(19): 9815-9823. https://doi.org/10.26355/eur-rev_202010_23191. PMID: 33090384

7. Fan X., Wu X., Crawford R., et al. Macro, micro, and molecular. Changes of the osteochondral interface in osteoarthritis development. Front Cell Dev Biol. 2021 May 10; 9: 659654. https://doi.org/10.3389/fcell.2021.659654. PMID: 34041240

8. Primorac D., Molnar V, RodE., et al. Knee osteoarthritis: A review of pathogenesis and state-of-the-art non-operative therapeutic considerations. genes (basel). 2020 Jul 26; 11(8): 854. https://doi.org/10.3390/genes11080854. PMID: 32722615

9. Jonsson H., Olafsdottir S., Sigurdardottir S., et al. Incidence and prevalence of total joint replacements due to osteoarthritis in the elderly: risk factors and factors associated with late life prevalence in the AGES-Reykjavik Study. BMC Musculoskelet Disord. 2016 Jan 12; 17: 14. https://doi.org/10.1186/s12891-016-0864-7. PMID: 26759053

10. Messier S.P., ResnikA.E., Beavers D.P., et al. Intentional weight loss in overweight and obese patients with knee osteoarthritis: Is more better? Arthritis Care Res (Hoboken). 2018 Nov; 70(11): 1569-1575. https://doi.org/10.1002/acr.23608. PMID: 29911741

11. Ganjeh S., Rezaeian Z.S., Mostamand J. Low level laser therapy in knee osteoarthritis: A narrative review. Adv Ther. 2020 Aug; 37(8): 3433-3449. https://doi.org/10.1007/s12325-020-01415-w. PMID: 32621270

12. Goldring S.R., Goldring M.B. Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk. Nat Rev Rheumatol. 2016 Nov; 12(11): 632-644. https://doi.org/10.1038/nrrheum.2016.148. PMID: 27652499

13. Madry H., Kon E., Condello V., et al. Early osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 2016 Jun; 24(6): 1753-1762. https://doi.org/10.1007/s00167-016-4068-3. PMID: 27000393

14. Zhou X., Liu G., Han B., et al. Different prevention and treatment strategies for knee osteoarthritis (KOA) with various lower limb exoskeletons - A comprehensive review. Robotica. 2021; 39(8): 1345-1367. https://doi.org/10.1017/S0263574720001216

15. Kolasinski S.L., Neogi T., HochbergM.C., et al. 2019 American College of rheumatology/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020 Feb; 72(2): 220-233. https://doi.org/10.1002/art.41142

16. Kan H.S., Chan P.K., Chiu K.Y., et al. Non-surgical treatment of knee osteoarthritis. Hong Kong Med J. 2019 Apr; 25(2): 127-133. https://doi.org/10.12809/hkmj187600. PMID: 30919810

17. Mancuso P., Raman S., Glynn A., et al. Mesenchymal stem cell therapy for osteoarthritis: The critical role of the cell secre-tome. Front Bioeng Biotechnol. 2019 Jan 29; 7: 9. https://doi.org/10.3389/fbioe.2019.00009. PMID: 30761298

18. Freitag J., Bates D., Wickham J., et al. Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial. Regen Med. 2019 Mar; 14(3): 213230. https://doi.org/10.2217/rme-2018-0161. PMID: 30762487

19. Grotle M., Hagen K.B., Natvig B., et al. Prevalence and burden of osteoarthritis: results from a population survey in Norway. J Rheumatol. 2008 Apr; 35(4): 677-684. PMID: 18278832

20. Vos T., Flaxman A.D., Naghavi M., et al.Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012 Dec 15; 380(9859): 2163-2196. https:// doi.org/10.1016/S0140-6736(12)61729-2. PMID: 23245607

21. Nguyen U.S., Zhang Y., Zhu Y, et al. Increasing prevalence of knee pain and symptomatic knee osteoarthritis: survey and cohort data. Ann Intern Med. 2011 Dec 6; 155(11): 725-732. https://doi.org/10.7326/0003-4819-155-11-201112060-00004. PMID: 22147711

22. Chery D.R., Han B., Li Q., et al. Early changes in cartilage pericellular matrix micromechanobiology portend the onset of post-traumatic osteoarthritis. Acta Biomater. 2020 Jul 15; 111: 267-278. https://doi.org/10.1016/j.actbio.2020.05.005. PMID: 32428685

23. Wallace I.J., Worthington S., Felson D.T., et al. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc Natl Acad Sci USA. 2017 Aug 29; 114(35): 9332-9336. https://doi.org/10.1073/pnas.1703856114.

24. PMID: 28808025 Deshpande B.R., Katz J.N., Solomon D.H., et al. Number of persons with symptomatic knee osteoarthritis in the US: Impact of race and ethnicity, age, sex, and obesity. Arthritis Care Res (Hoboken). 2016;68(12):1743-1750. https://doi.org/10.1002/acr.22897. PMID: 27014966

25. Buckwalter J.A., Mankin H.J. Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect. 1998; 47: 487-504. PMID: 9571450.

26. Eymard F., Parsons C., Edwards M.H., et al. Diabetes is a risk factor for knee osteoarthritis progression. Osteoarthritis Cartilage. 2015 Jun; 23(6): 851-859. https://doi.org/10.1016/j.joca.2015.01.013. PMID: 25655678

27. Cabral A.L.C.E.S., Jorge J.G., Dionisio VC. Biomechanical analysis during single-leg squat in individuals with knee osteoarthritis. Knee. 2021 Jan; 28: 362-370. https://doi.org/10.1016/j.knee.2020.12.031. PMID: 33494018

28. Guilak F. Biomechanical factors in osteoarthritis. Best Pract Res Clin Rheumatol. 2011 Dec; 25(6): 815-823. https://doi. org/10.1016/j.berh.2011.11.013. PMID: 22265263

29. Chen D., Shen J., Zhao W., et al. Osteoarthritis: toward a comprehensive understanding of pathological mechanism. Bone Res. 2017 Jan 17; 5: 16044. https://doi.org/10.1038/boneres.2016.44. PMID: 28149655

30. Mobasheri A., Rayman M.P., Gualillo O., et al. The role of metabolism in the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2017 May; 13(5): 302-311. https://doi.org/10.1038/nrrheum.2017.50. PMID: 28381830

31. He B., Jiang D. HOTAIR-induced apoptosis is mediated by sponging miR-130a-3p to repress chondrocyte autophagy in knee osteoarthritis. Cell Biol Int. 2020 Feb; 44(2): 524-535. https://doi.org/10.1002/cbin.11253. PMID: 31642563

32. Jiang L.F, Fang J.H., Wu L.D. Role of infrapatellar fat pad in pathological process of knee osteoarthritis: Future applications in treatment. World J Clin Cases. 2019 Aug 26; 7(16): 2134-2142. https://doi.org/10.12998/wjcc.v7.i16.2134. PMID: 31531309

33. HanX., Cui J., Xie K., et al. Association between knee alignment, osteoarthritis disease severity, and subchondral trabecular bone microarchitecture in patients with knee osteoarthritis: a crosssectional study. Arthritis Res Ther. 2020 Sep 4; 22(1): 203. https://doi.org/10.1186/s13075-020-02274-0. PMID: 32887657

34. Li G., Yin J., Gao J., et al. Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes. Arthritis Res Ther. 2013; 15(6): 223. https://doi.org/10.1186/ar4405. PMID: 24321104

35. Petersen K.K., Siebuhr A.S., Graven-Nielsen T., et al. Sensitization and serological biomarkers in knee osteoarthritis patients with different degrees of synovitis. Clin J Pain. 2016 Oct; 32(10): 841-848. https://doi.org/10.1097/AJP.0000000000000334. PMID: 26633689

36. McConnell S., Kolopack P., Davis A.M. The western ontario and mcmaster universities osteoarthritis index (WOMAC): a review of its utility and measurement properties. Arthritis Rheum. 2001; 45(5): 453-461. https://doi.org/10.1002/1529-0131(200110)45:5<453::aid-art365>3.0.co;2-w. PMID: 11642645

37. Crossley K.M., Macri E.M., Cowan S.M. The patellofemoral pain and osteoarthritis subscale of the KOOS (KOOS-PF): development and validation using the COSMIN checklist. Br J Sports Med. 2018; 52(17): 1130-1136. https://doi.org/10.1136/bjs-ports-2016-096776. PMID: 28258176

38. Hawker G.A., Mian S., Kendzerska T., French M. Measures of adult pain: visual analog scale for pain (VAS pain), numeric rating scale for pain (NRS pain), mcgill pain questionnaire (MPQ), short-form mcgill pain questionnaire (SF-MPQ), chronic pain grade scale (CPGS), short form-36 bodily pain scale (SF-36 BPS), and measure of intermittent and constant osteoarthritis pain (ICOAP). Arthritis Care Res (Hoboken). 2011; 63(11): S240-S252. https://doi.org/10.1002/acr.20543. PMID: 22588748

39. Kellgren J.H., Lawrence J.S. Radiological assessment of osteoarthrosis. Ann Rheum Dis. 1957; 16(4): 494-502. https://doi.org/10.1136/ard.16.4.494. PMID: 13498604

40. Babaei M., Javadian Y., Narimani H., et al. Correlation between systemic markers of inflammation and local synovitis in knee osteoarthritis. Caspian J Intern Med. 2019; 10(4): 383-387. https://doi.org/10.22088/cjim.10.4.383. PMID: 31814935

41. Bauer D.C., Hunter D.J., Abramson S.B., et al. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage. 2006; 14(8): 723-727. https://doi.org/10.1016/j.joca.2006.04.001. PMID: 16733093

42. Kraus V.B., Collins J.E., Hargrove D., et al. Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA biomarkers consortium. Ann Rheum Dis. 2017; 76(1): 186-195. https://doi.org/10.1136/annrheumdis-2016-209252. PMID: 27296323

43. Kumavat R., Kumar V, Malhotra R., et al. Biomarkers of joint damage in osteoarthritis: current status and future directions. Mediators Inflamm. 2021; 2021: 5574582. https://doi.org/10.1155/2021/5574582. PMID: 33776572

44. Prakash J., Gabdulina G., Trofimov S., Livshits G. Quantitative genetics of circulating hyaluronic acid (HA) and its correlation with hand osteoarthritis and obesity-related phenotypes in a community-based sample. 2017; 44(6): 522-530. https://doi.org/10.1080/03014460.2017.1334822. PMID: 28535729

45. Shi G.X., Tu J.F., Wang T.Q., et al. Effect of electro-acupuncture (EA) and manual acupuncture (MA) on markers of inflammation in knee osteoarthritis. J Pain Res. 2020; 13: 2171-2179. https://doi.org/10.2147/JPR.S256950. PMID: 32904642

46. Xin L., Wu Z., Qu Q., et al. Comparative study of CTX-II, Zn2+, and Ca2+ from the urine for knee osteoarthritis patients and healthy individuals. Medicine (Baltimore). 2017; 96 (32): e7593. https://doi.org/10.1097/MD.0000000000007593. PMID: 28796042

47. Chow Y.Y., Chin K.Y. The role of inflammation in the pathogenesis of osteoarthritis. Mediators Inflamm. 2020; 2020: 8293921. https://doi.org/10.1155/2020/8293921. PMID: 32189997

48. Stannus O., Jones G., Cicuttini F., et al. Circulating levels of IL-6 and TNF-a are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. 2010; 18(11): 1441-1447. https://doi.org/10.1016/jjoca.2010.08.016. PMID: 20816981

49. Crowther J.R. The ELISA guidebook. Springer Science & Business Media. 2001; 149. https://doi.org/10.1007/978-1-60327-254-4

50. Kan H.S., Chan P.K., Chiu K.Y., et al. Non-surgical treatment of knee osteoarthritis. Hong Kong Med J. 2019; 25(2): 127-133. https://doi.org/10.12809/hkmj187600. PMID: 30919810

51. Migliore A., Gigliucci G., Alekseeva L., et al. Treat-to-target strategy for knee osteoarthritis. International technical expert panel consensus and good clinical practice statements. Ther Adv Musculoskelet Dis. 2019; 11: 1759720X19893800. https://doi.org/10.1177/1759720X19893800. PMID: 31903099

52. Ringdahl E., Pandit S. Treatment of knee osteoarthritis. Am Fam Physician. 2011; 83(11): 1287-1292. PMID: 21661710

53. Bannuru R.R., OsaniM.C., VaysbrotE.E., et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019; 27(11): 1578-1589. https://doi.org/10.1016/jjoca.2019.06.011. PMID: 31278997

54. Thomas S., Browne H., Mobasheri A., Rayman M.P. What is the evidence for a role for diet and nutrition in osteoarthritis? Rheumatology (Oxford). 2018; 57(4): iv61-iv74. https://doi.org/10.1093/rheumatology/key011. PMID: 29684218

55. Robert-Lachaine X., Dessery Y., Belzile E.L., et al. Three-month efficacy of three knee braces in the treatment of medial knee osteoarthritis in a randomized crossover trial. J Orthop Res. 2020; 38(10): 2262-2271. https://doi.org/10.1002/jor.24634. PMID: 32077519

56. Jones A., Silva P.G., Silva A.C., et al. Impact of cane use on pain, function, general health and energy expenditure during gait in patients with knee osteoarthritis: a randomised controlled trial. Ann Rheum Dis. 2012; 71(2): 172-179. https://doi.org/10.1136/ard.2010.140178. PMID: 22128081

57. Steinmeyer J., BockF., Stove J., et al. Pharmacological treatment of knee steoarthritis: special considerations of the new german guideline. Orthop Rev (Pavia). 2018; 10(4): 7782. https://doi.org/10.4081/or.2018.7782. PMID: 30662685

58. Wright V, Chandler G.N., Morison R.A., Hartfall S.J. Intraarticular therapy in osteo-arthritis: comparison of hydrocortisone acetate and hydro-cortisone. Ann Rheum Dis. 1960; 19(3): 257261. https://doi.org/10.1136/ard.193.257. PMID: 13786828

59. Xu Z., He Z., Shu L., et al. Intra-articular platelet-rich plasma combined with hyaluronic acid injection for knee osteoarthritis is superior to platelet-rich plasma or hyaluronic acid alone in inhibiting inflammation and improving pain and function. Arthroscopy. 2021; 37(3): 903-915. https://doi.org/10.1016/j.ar-thro.2020.10.013. PMID: 33091549

60. Ong K.L., Runa M., Xiao Z., et al. Severe acute localized reactions following intra-articular hyaluronic acid injections in knee osteoarthritis. Cartilage. 2020: 1947603520905113. https://doi.org/10.1177/1947603520905113. PMID: 32063023

61. Borras-VerderaA., Calcedo-BernalV, Ojeda-Levenfeld J., Clavel-Sainz C. Efficacy and safety of a single intra-articular injection of 2% hyaluronic acid plus mannitol injection in knee osteoarthritis over a 6-month period. Rev Esp Cir Ortop Traumatol. 2012; 56(4): 274-280. https://doi.org/10.1016/j.recot.2012.02.004. PMID: 23594845

62. Rodriguez-Merchan E.C., De la Corte-Rodriguez H., Roman-Belmonte J.M. Initial treatment of knee osteoarthritis: oral and topical drugs. Comprehensive Treatment of Knee Osteoarthritis. 2020; 1: 1-10. https://doi.org/10.1007/978-3-030-44492-1_1

63. Roman-Blas J.A., Castaneda S., Sanchez-Pernaute O., et al. Combined treatment with chondroitin sulfate and glucosamine sulfate shows no superiority over placebo for reduction of joint pain and functional impairment in patients with knee osteoarthritis: a six-month multicenter, randomized, double-blind, placebo-controlled clinical trial. Arthritis Rheumatol. 2017; 69(1): 77-85. https://doi.org/10.1002/art.39819. PMID: 27477804

64. Liu C.-Y., Li C.-D., Wang L., et al. Function scores of different surgeries in the treatment of knee osteoarthritis: a PRISMA-compliant systematic review and network-meta analysis. Medicine (Baltimore). 2018; 97(21): e10828. https://doi.org/10.1097/MD.0000000000010828. PMID: 29794771

65. Kizaki K., El-KhechenH.A., YamashitaF., et al. Arthroscopic versus open osteochondral autograft transplantation (mosaicplasty) for cartilage damage of the knee: a systematic review. J Knee Surg. 2021; 34(1): 94-107. https://doi.org/rn.1055/s-0039-1692999. PMID: 31288271

66. Jackson R.W., Dieterichs C. The results of arthroscopic lavage and debridement of osteoarthritic knees based on the severity of degeneration: a 4- to 6-year symptomatic follow-up. Arthroscopy. 2003; 19(1): 13-20. https://doi.org/10.1053/jars.2003.50022. PMID: 12522398

67. Felson D.T. Arthroscopy as a treatment for knee osteoarthritis. Best Pract Res Clin Rheumatol. 2010; 24(1): 47-50. https://doi. org/10.1016/j.berh.2009.08.002. PMID: 20129199

68. Lespasio M.J., Piuzzi N.S., Husni M.E., et al. Knee osteoarthritis: a primer. Perm J. 2017; 21: 16-183. https://doi.org/10.7812/TPP/16-183. PMID: 29035179

69. RawalB.R., YadavA., Pare V. Life estimation of knee joint prosthesis by combined effect of fatigue and wear. Procedia Technology. 2016; 23: 60-67. https://doi.org/10.1016/j.protcy.2016.03.072

70. Tu Y., Ma T., Wen T., et al. Does unicompartmental knee replacement offer improved clinical advantages over total knee replacement in the treatment of isolated lateral osteoarthritis? A matched cohort analysis from an independent center. J Arthroplasty. 2020; 35(8): 2016-2021. https://doi.org/10.1016/j.arth.2020.03.021. PMID: 32265142

71. HeM., ZhongX., Li Z, et al. Progress in the treatment of knee osteoarthritis with high tibial osteotomy. Syst Rev. 2021; 10(1): 56. https://doi.org/10.1186/s13643-021-01601-z. PMID: 33583421

72. Gao L., Madry H., Chugaev D.V., et al. Advances in modern osteotomies around the knee: report on the association of sports traumatology, arthroscopy, orthopaedic surgery, rehabilitation (ASTAOR). Moscow International Osteotomy Congress 2017. J Exp Orthop. 2019 Feb 25; 6(1): 9. https://doi.org/10.1186/s40634-019-0177-5. PMID: 30805738

73. Chimutengwende-Gordon M., Donaldson J., Bentley G. Current solutions for the treatment of chronic articular cartilage defects in the knee. EFORT Open Rev. 2020 Mar 2; 5(3): 156-163. https://doi.org/10.1302/2058-5241.5.190031. PMID: 322965492020

74. Zhao L., Kaye A.D., Abd-ElsayedA. Stem cells for the treatment of knee osteoarthritis: a comprehensive review. Pain Physician. 2018 May; 21(3): 229-242. PMID: 29871367

75. Stratton S., Shelke N.B., Hoshino K., et al. Bioactive polymeric scaffolds for tissue engineering. Bioact Mater. 2016 Dec; 1(2): 93-108. https://doi.org/10.1016/j.bioactmat.2016.11.001. PMID: 28653043

76. Vacanti C.A., Kim W., Schloo B., et al. Joint resurfacing with cartilage grown in situ from cell-polymer structures. Am J Sports Med. 1994 Jul-Aug; 22(4): 48548-8. https://doi.org/10.1177/036354659402200408. PMID: 7943513

77. Wang Y., Blasioli D.J., Kim H.-J., et al. Cartilage tissue engineering with silk scaffolds and human articular chondrocytes. Biomaterials. 2006; 27(25): 443444-42. https://doi.org/10.1016/j.biomaterials.2006.03.050. PMID: 16677707

78. Wang B., Liu W., Xing D., et al. Injectable nanohydroxyapatite-chitosan-gelatin micro-scaffolds induce regeneration of knee subchondral bone lesions. Sci Rep. 2017; 7(1): 16709. https://doi.org/10.1038/s41598-017-17025-6. PMID: 29196647

79. Kangari P., Talaei-Khozani T., Razeghian-Jahromi I., Razmkhah M. Mesenchymal stem cells: amazing remedies for bone and cartilage defects. Stem Cell Res Ther. 2020 Nov 2; 11(1): 492. https://doi.org/10.1186/s13287-020-02001-1. PMID: 33225992

80. Zhao X., Hu D.A., Wu D., et al. Applications of Biocompatible Scaffold Materials in Stem Cell-Based Cartilage Tissue Engineering. Front Bioeng Biotechnol. 2021 Mar 25; 9: 603444. https://doi.org/10.3389/fbioe.2021.603444. PMID: 338424412021

81. Maqsood M., Kang M., Wu X., et al. Adult mesenchymal stem cells and their exosomes: sources, characteristics, and application in regenerative medicine. Life Sci. 2020 Sep 1; 256: 118002. https://doi.org/10.1016/j.lfs.2020.118002. PMID: 32585248

82. Friedenstein A.J., Chailakhyan R.K., Latsinik N.V., et al. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues: cloning in vitro and retransplantation in vivo. Transplantation. 1974 Apr; 17(4): 3313-40. https://doi.org/10.1097/00007890-197404000-00001. PMID: 4150881

83. Chamberlain G., Fox J., Ashton B., Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007 Nov; 25(11): 2739-2749. https://doi.org/10.1634/stem-cells.2007-0197. PMID: 17656645

84. Pittenger Me.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999 Apr 2; 284(5411): 14314-7. https://doi.org/10.1126/sci-ence.284.5411.143. PMID: 10102814

85. Hao Z., Song Z., Huang J., et al. The scaffold microenvironment for stem cell based bone tissue engineering. Biomater Sci. 2017 Jul 25; 5(8): 138213-92. https://doi.org/10.1039/c7bm00146k. PMID: 28447671

86. Andor B., Patrascu J.M., Florescu S., et al. Comparison of different knee implants used on patients with osteoarthritis control study. Mater Plast (Bucharest). 2016; 53(1): 1191-25.

87. Matta C., Szucs-Somogyi C., Kon E., et al. Osteogenic differentiation of human bone marrow-derived mesenchymal stem cells is enhanced by an aragonite scaffold. Differentiation. 2019 May-Jun; 107: 24-34. https://doi.org/10.1016/j.diff.2019.05.002. PMID: 31152959

88. Kayakabe M., Tsutsumi S., Watanabe H., et al. Transplantation of autologous rabbit BM-derived mesenchymal stromal cells embedded in hyaluronic acid gel sponge into osteochondral defects of the knee. Cytotherapy. 2006; 8(4): 343-353. https://doi.org/10.1080/14653240600845070. PMID: 16923610

89. Kim J.-H., Yun S., Seo M.-S., et al. Synergistic Effect of Carboxymethyl Chitosan and Adipose-Derived Mesenchymal Stem Cells on Osteoarthritis Model in Rabbits. Journal of Veterinary Clinics. 2020; 37(5): 261-269. https://doi.org/10.17555/jvc.2020.10.37.5.261

90. GuoX., Wang C., Zhang Y., et al. Repair oflarge articular cartilage defects with implants of autologous mesenchymal stem cells seeded into P-tricalcium phosphate in a sheep model. Tissue Eng. 2004 Nov-Dec; 10(11-12): 1818-1829. https://doi.org/10.1089/ten.2004.10.1818. PMID: 15684690

91. Zhang Z.-Z., Wang S.-J., Zhang J.-Y., et al. 3D-printed poly (e-caprolactone) scaffold augmented with mesenchymal stem cells for total meniscal substitution: a 12-and 24-week animal study in a rabbit model. Am J Sports Med. 2017 Jun; 45(7): 14971-511. https://doi.org/10.1177/0363546517691513. PMID: 28278383

92. Veber M., Vogler J., Knezevic M., et al. Combination of filtered bone marrow aspirate and biomimetic scaffold for the treatment of knee osteochondral lesions: cellular and early clinical results of a single centre case series. Tissue Eng Regen Med. 2020 Jun; 17(3): 3753-86. https://doi.org/10.1007/s13770-020-00253-9. PMID: 32329022

93. Koh Y.-G., Kwon O.-R., Kim Y.-S., Choi Y.-J. Comparative outcomes of open-wedge high tibial osteotomy with platelet-rich plasma alone or in combination with mesenchymal stem cell treatment: a prospective study. Arthroscopy. 2014 Nov; 30(11): 145314-60. https://doi.org/10.1016/j.arthro.2014.05.036. PMID: 25108907

94. Wang J., Zhou L., Zhang Y., et al. Mesenchymal stem cells-a promising strategy for treating knee osteoarthritis: a metaanalysis. Bone Joint Res. 2020 Oct; 9(10): 7197-28. https://doi.org/10.1302/2046-3758.910.BJR-2020-0031.R3. PMID: 33399474

95. Zhang R., Ma J., Han J., et al. Mesenchymal stem cell related therapies for cartilage lesions and osteoarthritis. Am J Transl Res. 2019 Oct 15; 11(10): 6275-6289. PMID: 31737182

96. AkgunI., UnluM.C., Erdal O.A., et al. Matrix-induced autologous mesenchymal stem cell implantation versus matrix-induced autologous chondrocyte implantation in the treatment of chondral defects of the knee: a 2-year randomized study. Arch Orthop Trauma Surg. 2015 Feb; 135(2): 251-263. https://doi.org/10.1007/s00402-014-2136-z. PMID: 25548122

97. Wong K.L., Lee K.B.L., Tai B.C., et al. Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years’ followup. Arthroscopy. 2013 Dec; 29(12): 2020-2028. https://doi.org/10.1016/j.arthro.2013.09.074. PMID: 24286801

98. EmadedinM., Labibzadeh N., Liastani M.G., et al. Intra-articular implantation of autologous bone marrow-derived mesenchymal stromal cells to treat knee osteoarthritis: a randomized, tripleblind, placebo-controlled phase 1/2 clinical trial. Cytotherapy. 2018 Oct; 20(10): 123812-46. https://doi.org/10.1016/j.jcyt.2018.08.005. PMID: 30318332

99. Vangsness Jr C.T., Jack Farr I., Boyd J., et al. Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Joint Surg Am. 2014 Jan 15; 96(2): 90-98. https://doi.org/10.2106/JBJS.M.00058. PMID: 24430407.2014

100. Soler R., Orozco L., Munar A., et al. Final results of a phase I-II trial using ex vivo expanded autologous mesenchymal stromal cells for the treatment of osteoarthritis of the knee confirming safety and suggesting cartilage regeneration. Knee. 2016 Aug; 23(4): 647654. https://doi.org/10.1016/j.knee.2015.08.013. PMID: 26783191

101. Gupta P.K., Chullikana A., Rengasamy M., et al. Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint. Arthritis Res Ther. 2016 Dec 20; 18(1): 301. https://doi.org/10.1186/s13075-016-1195-7. PMID: 27993154

102. Al-Najar M., Khalil H., Al-Ajlouni J., et al. Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study. J Orthop Surg Res. 2017 Dec 12; 12(1): 190. https://doi.org/10.1186/s13018-017-0689-6. PMID: 29233163

103. Garay-Mendoza D., Villarreal-Martmez L., Garza-Bedolla A., et al. The effect of intra-articular injection of autologous bone marrow stem cells on pain and knee function in patients with osteoarthritis. Int J Rheum Dis. 2018 Jan; 21(1): 140-147. https://doi.org/10.1111/1756-185X.13139. PMID: 28752679

104. Matas J., Orrego M., Amenabar D., et al. Umbilical cord-derived mesenchymal stromal cells (MSCs) for knee osteoarthritis: Repeated MSC dosing is superior to a single MSC dose and to hyaluronic acid in a controlled randomized phase I/II trial. Stem Cells Transl Med. 2019 Mar; 8(3): 215-224. https://doi.org/10.1002/sctm.18-0053. PMID: 30592390

105. Nasb M., Liangjiang H., Gong C., Hong C. Human adipose-derived mesenchymal stem cells, low-intensity pulsed ultrasound, or their combination for the treatment of knee osteoarthritis: study protocol for a first-in-man randomized controlled trial. BMC Musculoskelet Disord. 2020 Jan 15; 21(1): 33. https://doi.org/10.1186/s12891-020-3056-4. PMID: 3194148

106. MizukamiA., SwiechK. Mesenchymal stromal cells: from discovery to manufacturing and commercialization. Stem Cells Int. 2018 Apr 11; 2018: 4083921. https://doi.org/10.1155/2018/4083921. PMID: 30057622